A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

Authors: Charles S. Fuchs, Sérgio Jobim Azevedo, Takuji Okusaka, Jean‐Luc Van Laethem, Lara Lipton, Hanno Riess, Cezary Szczylik, Malcolm J. Moore, Marc Peeters, G. Bodoky, Masafumi Ikeda, Bohuslav Melichar, Radim Němeček, S. Ohkawa, Anna Świeboda-Sadlej, Sergei Tjulandin, Eric Van Cutsem, Robert D. Loberg, Vincent Haddad, Jennifer Gansert, Bruce Allen Bach, Alfredo Carrato - Annals of Oncology 2015 cited by 164